甲状腺性眼病患者外周血细胞因子的研究

曾志; 袁卫红

甲状腺性眼病患者外周血细胞因子的研究

曾志 , 袁卫红

文章导航 > 国际放射医学核医学杂志 > 2008, 32 > 6: (332-335)

引用本文:

Citation:

甲状腺性眼病患者外周血细胞因子的研究

曾志,
袁卫红

650101 昆明, 昆明医学院第二附属跃院核医学科
基金项目:
云南省教育厅科学研究基金项目(06Z177C)

Research of peripheral cytokine level in thyroid eye disease patients

Department of Nuclear Medicine, The Second Affiliated Hospital of Kunming University, Kunming 650101, China

摘要: 甲状腺性眼病(TED)往往与器官特异性自身免疫有关,已经发现多种细胞因子水平及其变化与TED的临床表现、治疗疗效和预后有一定的关系。对TED患者外周血中的某些细胞因子(包括白细胞介素1β、白细胞介素2、白细胞介素6、白细胞介素8、肿瘤坏死因子α、胰岛素样因子1)的水平进行相关性研究意义重大。
- Graves眼病 /
- 白细胞介素类 /
- 肿瘤坏死因子α /
- 胰岛素样因子1
Abstract: Thyroid eye disease often associated with organ-specific autoimmune. Relationship has been found between a variety of serum cytokine level and clinical expression as well as the response to the treatment of patients with thyroid eye disease. The research of peripheral cytokine level in thyroid eye disease patients, including interleukin-1β, interleukin-2, interleukin-6, interleukin-8, tumor necrosis factor-α, insulin-like growth factor-1 is important.
- Graves ophthalmopathy /
- Interleukins /
- Tumor necrosis factor alpha /
- Insulin-line grouth factor 1
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Xia N,Zhou S,Liang Y,et al. CD4⁺ T cells and the Th1/Th2 imbalance are implicated in the pathogenesis of Graves' ophthalmopathy[J]. Int J Mol Med,2006,17(5):911-916.
[2]	Hunt PJ,Marshall SE,Weetman AP,et al. Cytokine gene polymorphisms in autoimmune thyroid disease[J]. J Clin Endocrinol Metab,2000,85(5):1984-1988.
[3]	kumar S,Bahn RS,Relative overexpression of macrophage derived cytokines in orbital adipose tissue from patients with graves' ophthalmopathy[J]. J Clin Endocrinol Metab,2003,88(9):4246-4250.
[4]	Inoue A,Koizumi S,Matsuda A,et al. Graves' hyperthyroidism showing transient hypothyroidism during interferon therapy for chronic hepatitis type C[J]. Endocr J,2005,52(3):293-298.
[5]	Vaidya B,Oakes EJ,Imrie H,et al. CTLA4 gene and Graves' disease:association of Graves' disease with the CTLA4 exon 1 and intron 1 polymorphisms,but not with the promoter polymorphism[J]. Clin Endocrinol(Oxf),2003,58(6):732-735.
[6]	Han R,Smith TJ. Induction by IL-1beta of tissue inhibitor of metalloproteinase-1 in human orbital fibroblasts:modulation of gene promoter activity by IL-4 and IFN-gamma[J],J Immunol,2005,174(5):3072-3079.
[7]	Sera N,Kawakami A,Nakashima T,et al. Fas/FasL mediated apoptpsis of thyrocytes in Graves' disease[J]. Clin Exp Immunol,2001,124(2):197-207.
[8]	Koumas L,Smith TJ,Feldon S,et al. Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes[J],Am J Pathol,2003,163(4):1291-1300.
[9]	Hall MC,Yong DA,Waters JG,et al. The comparative role of activator protein 1 and smad factors in the regulation of Timp-1 and MMP-1 gene expression by transforming growth factor-beta 1[J]. J Biol Chem,2003,278(12):10304-10313.
[10]	Pimentel-Muiños FX,Muñoz-Femández MA,Fresno M. Control of T lymphocyte activation and IL-2 receptor expression by endog-enously secreted lymphokines[J]. J Immunol,1994,152(12):5714-5722.
[11]	Cawood T,Moriarty P,O'Shea D.Recent development in thyroid eye disease[J],BMJ,2004,329(7462):385-390.
[12]	Brand OJ,Lowet CE,Heward JM,et al. Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs[J]. Clin Endocrinol(oxf),2007,66(4):508-512.
[13]	Simsek G,Karter Y,Aydin S,et al. Osteoporotic cytokines and bone metabolism on rats with induced hyperthyroidism; changes as a result of reversal to euthyroidism[J]. Chin J Physiol,2003,46(4):181-186.
[14]	Wakelkamp IM,Gerding MN,Van Der Meer JW,et al. Both Th1- and Th2-derived cytokines in serum are elevated in Graves' ophthalmopathy[J]. Clin Exp Immunol,2000,121(3):453-457.
[15]	Wang SH,Bretz JD,Phelps E,et al. A unique combination of inflaramatoy cytokines enhances apoptosis of thyroid follicular cells and transforms nondestructive thyroiditis in experimental autoimmune thyroiditis[J],J Immunol,2002,168(5):2470-2474.
[16]	Bartalena L,Brogioni S,Grasso L,et al. Lnterleukiir-6 and the thyroid[J]. Eur J Endocrinol,1995,132(4):386-393.
[17]	Campbell IK,Roberts LJ,Wicks IP,et al. Molecular targets in immune mediated disease the case of tumour necrosis factor and rheumatoid arthritis[J]. Immunol Cell Biol,2003,81(5):354-366.
[18]	Quadbeck B,Stucke M,Eckstein AK,et al. Dysregulation of TNF/TNFR superfamily members:a systemic link between intra-and extrathyroidal manifestations in Graves' disease[J]. Scand J Immunol,2006,64(5):523-530.
[19]	Poulaki V,Mitsiades GS,McMullan C,et al. Regulation of vascular endothelial growth factor expression by insulin-like growth factor I in thyroid carcinomas[J]. J Clin Endocrinol Metab,2003,88(11):5392-5398.
[20]	Senturk T,Kozaci LD,Kok F,et al. Proinflammatory cytokine levels in hyperthyroidism[J]. Clin Invest Med,2003,26(2):58-63.
[21]	Díez JJ,Hernanz A,Medina S,et al. Serum concentrations of tumour necrosis factor-alpha (TNF-alpha)and soluble TNF-alpha receptor p55 in patients with hypothyroidism and hyperthyroidism before and after normalization of thyroid function[J]. Clin Endocrinol(Oxf),2002,57(4):515-521.
[22]	Pichler R,Maschek W,Hatz1-Griesenhofer M,et al. Soluble tumour necrosis factor-alpha receptor I and interleukin-6 as markers of activity in thyrotoxic Graves' disease[J]. Horm Metab Res,2003,35(7):427-433.
[23]	Van den Berghe G. Endocrine evaluation of patients with critical illness[J]. Endocrinol Metab Clin North Am,2003,32(2):385-410.
[24]	Mitsiades CS,Poulaki V,Mitsiades N. The role of apoptosis-inducing receptors of the tumor necrosis factor family in thyroid cancer[J]. J Endocrinol,2003,178(2):205-216.
[25]	Mincione G,Esposito DL,Di Marcantonio MC,et al. TGF-beta 1 modulation of IGF-I signaling pathway in rat thyroid epithelial cells[J]. Exp Ceil Res,2003,287(2):411-423.
[26]	Geenen V. The thymic insulin-like growth factor axis:involvement in physiology and disease[J]. Horm Metab Res,2003,35(11-12):656-663.
[27]	Geenen V,Brilot F. Role of the thymus in the development of tolerance and autoimmunity towards the neuroendocrine system[J]. Ann NY Acad Sci,2003,992:186-195.
[28]	Savino W,Postel-Vinay MC,Smaniotto S,et al. The thymus gland:a target organ for growth hormone[J]. Scand J Immunol,2002,55(5):442-452.

[1]	刘永哲 , 金顺子 . 白细胞介素24的研究进展. 国际放射医学核医学杂志, 2007, 31(3): 179-182.
[2]	沈晓华 , 黄寨荣 , 杨永青 . 急性白血病患者血脂、β₂-微球蛋白及肿瘤坏死因子α水平测定的临床意义. 国际放射医学核医学杂志, 2010, 34(2): 91-93. doi: 10.3760/cma.j.issn.1673-4114.2010.02.007
[3]	孙启和 , 孙彬 , 杨永青 . 冠心病患者血清细胞因子和超敏C-反应蛋白水平测定的临床意义. 国际放射医学核医学杂志, 2010, 34(5): 291-294. doi: 10.370/cma.j.issn.1673-4114.2010.05.010
[4]	王芹 , 杜利清 , 徐畅 , 孙志娟 , 王彦 , 宋力 , 李进 , 樊飞跃 , 刘强 . 白细胞介素21基因联合放射对肺癌细胞生长的协同抑制作用. 国际放射医学核医学杂志, 2014, 38(3): 161-163. doi: 10.3760/cma.j.issn.1673-4114.2014.03.005
[5]	吴莹 , 孙金锴 , 李志旺 . 白细胞介素-1和肿瘤坏死因子的辐射防护作用. 国际放射医学核医学杂志, 1996, 20(6): 268-270.
[6]	黄春玲 , 查金顺 , 蒋婷吟 . 甲状腺功能亢进症患者血浆中TNF-α1和IL-2水平的临床分析. 国际放射医学核医学杂志, 2012, 36(2): 92-93, 120. doi: 10.3760/cma.j.issn.1673-4114.2012.02.008
[7]	赵若愚 , 鲍逸民 , 杨永青 . 血浆心肌细胞损伤标志物检测急性心肌梗死患者心肌损伤的临床研究. 国际放射医学核医学杂志, 2014, 38(4): 235-238. doi: 10.3760/cma.j.issn.1673-4114.2014.04.007
[8]	袁卫红 , 张怡 , 罗志航 . 内分泌性眼病患者外周血中白细胞介素6和胰岛素样生长因子1水平变化的研究. 国际放射医学核医学杂志, 2008, 32(3): 167-169.
[9]	张涵 , 陈瑶 , 段炼 . ¹³¹I联合糖皮质激素治疗Graves眼病疗效的Meta分析. 国际放射医学核医学杂志, 2022, 46(11): 669-678. doi: 10.3760/cma.j.cn121381-202111009-00237
[10]	段炼 , 陆克义 , 陈霞 , 李险峰 , 孙斌 , 赵德善 , 刘建中 , 李思进 . ¹³¹I治疗Graves病对甲状腺相关眼病转归的相关因素分析. 国际放射医学核医学杂志, 2011, 35(4): 230-234. doi: 10.3760/cma.j.issn.1673-4114.2011.04.009

点击查看大图

计量

文章访问数: 1505
HTML全文浏览量: 120
PDF下载量: 2

甲状腺性眼病患者外周血细胞因子的研究

曾志
袁卫红

650101 昆明, 昆明医学院第二附属跃院核医学科

收稿日期: 2008-08-15

基金项目: 云南省教育厅科学研究基金项目(06Z177C)

关键词:

摘要: 甲状腺性眼病(TED)往往与器官特异性自身免疫有关,已经发现多种细胞因子水平及其变化与TED的临床表现、治疗疗效和预后有一定的关系。对TED患者外周血中的某些细胞因子(包括白细胞介素1β、白细胞介素2、白细胞介素6、白细胞介素8、肿瘤坏死因子α、胰岛素样因子1)的水平进行相关性研究意义重大。